Vertex AI Search for healthcare's new, multimodal search capabilities can help organizations give doctors, nurses, and others a more comprehensive view of patient health. Google Cloud Logo ...

TIARA 2025, the two-day techno cultural fest organized by St Joseph Engineering College (SJEC), Mangaluru, was inaugurated on ...

Pilgrim, a leading Indian clean beauty brand, has secured Rs200 crore in a new funding round, valuing the company at approximately Rs3,000 crore pre-money. This investment, a mix of primary and ...

Moving to advance agentic and physical AI adoption, NVIDIA, Alphabet and Google are announcing multiple collaborations, including in drug discovery, robotics in manufacturing and green energy.

In a report released today, William Pickering from Bernstein maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with ...

RBC Capital raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $420 from $408 and keeps a Sector Perform rating on the shares.

Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.60% to $484.82 Monday, on what proved to be an all-around favorable ...

Vertex Software faces strong competition and slower growth, leading to a neutral rating. See why VERX stock remains pricey ...

ICER's evaluation of Vertex Pharmaceuticals' non-opioid pain drug, Journavx, finds cost-effectiveness related to potential ...

Vertex Pharmaceuticals Inc. closed 5.23% below its 52-week high of $519.88, which the company achieved on November 8th.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Receive News & Ratings for Vertex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vertex and related companies with ...